BioSpace

BioTime Reports Pro Forma Gain On Deconsolidation Of OncoCyte Subsidiary

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT:BTX), a clinical-stage biotechnology company developing and commercializing products addressing degenerative diseases, today announced the ...
Business Wire

Asterias Biotherapeutics, Inc., a Subsidiary of BioTime, Inc., Acquires Geron’s Embryonic Stem Cell Assets

MENLO PARK, Calif. & ALAMEDA, Calif.--(BUSINESS WIRE)--Asterias Biotherapeutics, Inc. and BioTime, Inc. (NYSE MKT: BTX) jointly announced today the closing of the transactions under the Asset ...
Business Wire

BioTime Updates Timeline for Distribution of AgeX Shares to BioTime Shareholders

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that its Board of Directors intends to ...
FierceBiotech

Asterias Biotherapeutics, Inc., a Subsidiary of BioTime, Inc., Acquires Geron's Embryonic Stem Cell Assets

Asterias Biotherapeutics, Inc. and BioTime, Inc. (NYSE MKT: BTX) jointly announced today the closing of the transactions under the Asset Contribution Agreement (the "Agreement") with Geron Corporation ...
BioSpace

BioTime Updates Timeline for Distribution of AgeX Shares to BioTime Shareholders

Regulatory Approvals In-Process; New Record Date to be Set Shortly ALAMEDA, Calif.--(BUSINESS WIRE)-- BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative ...